{"nct_id":"NCT05261490","title":"Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer","status":"TERMINATED","status_verified_date":"2024-10","start_date":"2022-08-01","start_date_type":"ACTUAL","primary_completion_date":"2023-10-11","primary_completion_date_type":"ACTUAL","completion_date":"2024-02-15","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["PFE"]}